Impact of school-supervised ultra-long-acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study

被引:1
|
作者
Nally, Laura M. [1 ]
Sherr, Jennifer L. [1 ]
Tichy, Eileen [1 ]
Weyman, Kate [1 ]
Urban, Andrea [1 ]
Shabanova, Veronika [1 ,2 ]
McCollum, Sarah [1 ]
Steffen, Amy [1 ]
Tamborlane, William V. [1 ]
Van Name, Michelle [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Biostat, New Haven, CT USA
关键词
degludec; diabetic ketoacidosis; glargine; school; type; 1; diabetes; DEGLUDEC;
D O I
10.1111/dme.15123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In youth with type 1 diabetes (T1D), high haemoglobin A1c (HbA1c) levels are associated with an increased risk for diabetic ketoacidosis (DKA). Aims: This study examined whether daily school-supervised basal insulin injections were feasible and if they reduced the risk of morning ketosis in children and adolescents with high HbA1c levels. We hypothesized that supervised glargine and degludec would reduce the risk of ketosis and that the prolonged action of degludec would protect from ketosis after consecutive days of unsupervised injections. Materials & Methods: After a 2-4-week run-in, youth (10-18 years, HbA1c >= 8.5%) managing T1D with injections were randomized to school-supervised administration of degludec or glargine for 4 months. School nurses observed daily blood beta-hydroxybutyrate (BHB) and glucose checks. During COVID closures, the research team supervised procedures remotely. Results: Data from 28 youth (age 14.3 +/- 2.3 years, HbA1c 11.4 +/- 1.9%, 64% F) were analysed. School-supervised injections of both basal insulins for 1-4 days progressively lowered the percent of participants with elevated BHB. The percent of participants with elevated BHB (>= 0.6 mmol/L) after 2 days of unsupervised basal insulin doses at home was greater in the glargine than degludec group but had a high p-value (17.2% vs. 9.0%, p = 0.3). HbA1c was unchanged in both groups. Discussion: In youth with T1D at high risk for DKA, daily supervised long-acting insulin administration decreased the probability of elevated ketone levels on subsequent school days, regardless of basal insulin type. A larger sample size may have demonstrated that the longer action profile of degludec would offer additional protection from ketosis during days of not attending school. Conclusion: Engaging school-based caregivers in management of youth with T1D on injected insulin may decrease clinically significant ketosis and minimize acute complications of diabetes.
引用
收藏
页数:9
相关论文
共 17 条
  • [1] Supervised Basal Insulin Injections Prevent Ketosis in Youth with Type 1 Diabetes (T1D)
    Nally, Laura M.
    Sosnoski, Olivia K.
    Sherr, Jennifer
    Tichy, Eileen M.
    Weyman, Kate
    Steffen, Amy
    Mccollum, Sarah
    Shabanova, Veronika
    Tamborlane, William V.
    Van Name, Michelle A.
    DIABETES, 2021, 70
  • [2] High Rates of Unrecognized Ketosis in Youth with T1D and Elevated A1c Levels
    Nally, Laura M.
    Elahi, Shabnam
    Van Name, Michelle A.
    Steffen, Amy
    Tichy, Eileen M.
    Urban, Andrea Dann
    Weyman, Kate
    Tamborlane, William V.
    DIABETES, 2019, 68
  • [3] Lower Basal to Total Daily Insulin Ratio is Associated With Lower A1c in Youth With Type 1 Diabetes (T1D) Using Pump Therapy
    Mehta, Sanjeev N.
    Gaffney, Kaitlin C.
    Volkening, Lisa K.
    Nansel, Tonja R.
    Haynie, Denise
    Laffel, Lori M.
    DIABETES, 2012, 61 : A327 - A327
  • [4] Traditional Risk Factors for Elevated A1C Persist among Youth with T1D Using CGM-Results from the 4T Study 1
    Kim, Jaehyun
    Zaharieva, Dessi P.
    Bishop, Franziska K.
    Scheinker, David
    Johari, Ramesh
    Desai, Manisha
    Hood, Korey K.
    Maahs, David M.
    Addala, Ananta
    DIABETES, 2023, 72
  • [5] Do Parent Goals for A1c and Blood Glucose (BG) Impact Glycemic Control in Youth with Type 1 Diabetes (T1D)?
    Boot, Maya
    Volkening, Lisa K.
    Butler, Deborah A.
    Laffel, Lori M.
    DIABETES, 2011, 60 : A340 - A341
  • [6] 4T Study-Early CGM Initiation and Tighter Glucose Targets Improves A1C in Youth with T1D
    Prahalad, Priya
    Ding, Victoria
    Zaharieva, Dessi P.
    Addala, Ananta
    Bishop, Franziska K.
    Scheinker, David
    Johari, Ramesh
    Desai, Manisha
    Hood, Korey K.
    Maahs, David M.
    DIABETES, 2023, 72
  • [7] Transition from Multiple Daily Injections (MDI) to Omnipod 5 Automated Insulin Delivery System Improves A1C in Type 1 Diabetes (T1D)
    Shah, Viral
    Criego, Amy B.
    Carlson, Anders L.
    Bhargava, Anuj
    Bode, Bruce W.
    Brown, Sue A.
    Forlenza, Gregory P.
    Levy, Carol J.
    Mehta, Sanjeev N.
    Laffel, Lori M.
    Aleppo, Grazia
    Buckingham, Bruce A.
    Desalvo, Daniel
    Hirsch, Irl B.
    Macleish, Sarah A.
    Pinsker, Jordan E.
    Ly, Trang T.
    DIABETES, 2021, 70
  • [8] 4T Study: Tighter Glucose Target Settings with Early CGM Initiation Further Improves A1C in Youth with T1D
    Prahalad, Priya
    Ding, Victoria
    Zaharieva, Dessi P.
    Addala, Ananta
    Bishop, Franziska K.
    Scheinker, David
    Johari, Ramesh
    Desai, Manisha
    Hood, Korey K.
    Maahs, David M.
    DIABETES, 2022, 71
  • [9] A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D)
    Perchard, R.
    Magee, L.
    Whatmore, A.
    Ivison, F.
    Murray, P.
    Stevens, A.
    Mughal, M. Z.
    Ehtisham, S.
    Campbell, J.
    Ainsworth, S.
    Marshall, M.
    Bone, M.
    Doughty, I.
    Clayton, P. E.
    ENDOCRINE CONNECTIONS, 2017, 6 (04): : 225 - 231
  • [10] Impact of Treatment Persistence on A1C Trends among Patients with T2D Newly Initiated on Basal Insulin
    Zhou, Fang Liz
    Xie, Lin
    Pan, Chunshen
    Vaidya, Neel
    Ye, Fen
    Preblick, Ronald
    Meneghini, Luigi
    DIABETES, 2017, 66 : A213 - A213